India to Sri Lanka: Rituximab Export Trade Route

The India to Sri Lanka Rituximab corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $2.2M USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's rituximab manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $72.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with rituximab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 13.5%, placing it at rank #14 among India's top rituximab export destinations globally.

On the import side, key buyers of Indian rituximab in Sri Lanka include STATE PHARMACEUTICALS CORPORATION , STATE PHARMACEUTICALS CORPORATION O, ABC PHARMA SERVICES (PVT) LTD and 4 others. STATE PHARMACEUTICALS CORPORATION is the single largest importer with 6 shipments valued at $839.8K USD.

India's rituximab exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED , PLEASANT EXPORTS — together account for 100% of total trade value on this route. The average shipment value of $72.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as 5076 vials rituximab injection 500mgritu and 7500 vials of rituximab injection 500mgrituxirel 500mg rituxirel 500mg, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE PHARMACEUTICALS CORPORATION is the largest importer with 6 shipments worth $839.8K USD — representing 39% of all rituximab imports from India on this route. A total of 7 buyers are active on this corridor.